Menlo Park, CA, United States of America

Achal Singh Achrol

This inventor holds 1 USPTO granted patent and 12 published patent applications and 1 EPO patent. Top assignee: Genestream, Inc.. Active years: 2014.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Achal Singh Achrol: Innovator in Microfluidic Technology

Introduction

Achal Singh Achrol is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of microfluidics, particularly in the isolation of particles from biological fluids. His innovative approach has the potential to enhance medical diagnostics and treatment.

Latest Patents

Achal Singh Achrol holds a patent for a "Microfluidic method and system for isolating particles from biological fluid." This invention involves a sophisticated system and method for isolating particles from a biological fluid sample. The process includes obtaining a sample from a source, tagging the particles with magnetic agents, and sorting them based on their interaction with a magnetic field. This technology not only improves the efficiency of particle isolation but also allows for the return of processed fluid back to its source, potentially with therapeutic agents.

Career Highlights

Achrol is currently associated with Genestream, Inc., where he applies his expertise in microfluidics to develop innovative solutions. His work is instrumental in advancing the capabilities of medical technologies, particularly in the area of diagnostics.

Collaborations

Achal collaborates with Palaniappan Sethu, a fellow innovator in the field. Their combined efforts contribute to the development of cutting-edge technologies that address complex challenges in medical science.

Conclusion

Achal Singh Achrol's contributions to microfluidic technology exemplify the impact of innovation in healthcare. His patent and ongoing work at Genestream, Inc. highlight the importance of advancements in isolating biological particles for improved medical outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…